Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study. Issue 4 (October 2021)
- Record Type:
- Journal Article
- Title:
- Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study. Issue 4 (October 2021)
- Main Title:
- Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study
- Authors:
- Hsu, Wan-Yu
Anderson, Annika
Rowles, William
Peters, Katherine E.
Li, Vicki
Stone, Katie L.
Ashbrook, Liza H.
Gelfand, Amy A.
Bove, Riley M. - Abstract:
- Background: Sleep disturbances are commonly reported by people with multiple sclerosis (PwMS). However, optimal management of sleep disturbances is uncertain, and objective studies of sleep quality in PwMS are scarce. Objectives: To determine the effect of exogenous melatonin on sleep quality and sleep disturbances in PwMS. Methods: Thirty adult PwMS reporting sleep difficulties were recruited in a randomized, controlled, double-blind cross-over study. They took either melatonin or placebo for 2 weeks, and the opposite for the following 2 weeks. During weeks 2 and 4, an actigraph was used to capture mean total sleep time and sleep efficiency. Patient-reported outcomes (PROs) were collected at weeks 0, 2 and 4. Results: Melatonin use significantly improved mean total sleep time ( p = 0.03), with a trend towards higher sleep efficiency ( p = 0.06). No PROs were significantly different; there was a trend for melatonin use to decrease mean Insomnia Severity Index score ( p = 0.07), improve Pittsburgh Sleep Quality Index sleep quality component ( p = 0.07), and improve NeuroQoL-Fatigue ( p = 0.06). No other PROs showed differences between melatonin and placebo; nor did step count measured by actigraphy (all p > 0.45). Conclusion: These results provide preliminary evidence that melatonin, a low-cost, over-the-counter supplement, could improve objective measures of sleep quality in PwMS.
- Is Part Of:
- Multiple sclerosis journal, experimental, translational and clinical. Volume 7:Issue 4(2021)
- Journal:
- Multiple sclerosis journal, experimental, translational and clinical
- Issue:
- Volume 7:Issue 4(2021)
- Issue Display:
- Volume 7, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 7
- Issue:
- 4
- Issue Sort Value:
- 2021-0007-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-10
- Subjects:
- melatonin -- multiple sclerosis -- sleep disturbance -- sleep quality -- actigraph -- patient-reported outcomes
Multiple sclerosis -- Periodicals
616.834 - Journal URLs:
- https://journals.sagepub.com/home/mso ↗
http://www.uk.sagepub.com/home.nav ↗
http://mso.sagepub.com/ ↗ - DOI:
- 10.1177/20552173211048756 ↗
- Languages:
- English
- ISSNs:
- 2055-2173
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18654.xml